Services

Professional and Cost-Saving Solutions

Whole Cell Biocatalysts

For many biocatalytic processes, purified enzymes represent the core catalytic machinery; however, enzyme purification, stabilization, and immobilization often introduce significant time, cost, and technical complexity. Whole cell biocatalysts offer a compelling alternative by utilizing living or non-growing microbial cells as self-contained catalytic units. In these systems, enzymes operate within or on the surface of their natural cellular environment, benefiting from intrinsic stabilization, cofactor regeneration, and pre-immobilization. Creative Enzymes provides comprehensive services for the design, development, optimization, and scale-up of whole cell biocatalysts, integrating host engineering, surface display technologies, and process optimization to deliver robust, reusable, and industrially relevant biocatalytic solutions.

Background: From Purified Enzymes to Whole Cell Biocatalysis

Limitations of Purified Enzyme Systems

Biocatalysis is a key technology in modern industrial biotechnology, supporting selective and sustainable transformations in pharmaceuticals, fine chemicals, food, and environmental applications. Traditionally, purified enzymes have been used as biocatalysts; however, enzyme purification is often time-consuming, costly, and technically demanding at scale. In addition, purified enzymes may suffer from limited stability and typically require immobilization to enable reuse and continuous processing, adding further process complexity.

Advantages of Whole Cell Biocatalysts

Whole cell biocatalysis provides a practical alternative to purified enzyme systems. In this approach, microorganisms such as Escherichia coli or yeast are engineered to express target enzymes that function within the cellular environment. The host cell acts as a natural immobilization matrix, protecting enzymes from degradation and enabling repeated use without additional immobilization steps.

Functional Integration and Process Efficiency

Whole cell systems offer further advantages, including inherent cofactor regeneration, compatibility with multi-enzyme pathways, and simplified catalyst recovery. These features make them particularly suitable for redox reactions and cascade processes. To address challenges such as mass-transfer limitations and interference from endogenous enzymes, strategies such as enzyme surface display have been developed, improving substrate accessibility while retaining cellular stability.

Leveraging extensive expertise in enzyme engineering and bioprocess development, Creative Enzymes designs whole cell biocatalysts that balance catalytic performance with operational simplicity for industrial applications.

What We Offer: Comprehensive Whole Cell Biocatalyst Development Services

Creative Enzymes provides end-to-end services for the development of whole cell biocatalysts, from host selection and genetic design to industrial-scale validation. Our offerings are modular and customizable, enabling clients to engage at any stage of development.

Our professional services include:

  • Selection of suitable or custom microbial hosts for whole cell biocatalysis and enzyme display
  • Design and development of enzyme display methods, including surface anchoring and periplasmic localization
  • Rational design of whole cell biocatalysts and associated bioprocesses, integrating reaction and host engineering
  • Quantification and optimization of biocatalytic efficiency, including activity, selectivity, and stability
  • Scaling-up of whole cell biocatalysts to industrially relevant production volumes

With advanced molecular biology platforms and proven bioprocess expertise, we deliver whole cell systems optimized for performance, robustness, and scalability.

Service Details: Technologies and Platforms for Whole Cell Biocatalysts

Whole Cell Biocatalysis Using Intracellular Enzymes

In many applications, enzymes expressed within the cytoplasm or periplasm of microbial hosts are sufficient to catalyze desired reactions. The cellular environment provides natural stabilization, while endogenous metabolic pathways can support cofactor regeneration.

This approach is particularly effective for reactions involving small, membrane-permeable substrates and products.

Surface-Displayed Whole Cell Biocatalysts

To overcome mass transfer limitations associated with intracellular catalysis, surface display technologies have been widely adopted.

Surface-displayed enzymes are anchored to the outer cell membrane or cell wall, providing direct access to substrates while retaining the advantages of whole cell systems.

Anchor Proteins and Display Systems

We design and implement a variety of anchor protein systems tailored to Gram-negative and Gram-positive microorganisms. Factors such as enzyme size, folding requirements, and reaction conditions are carefully considered.

Integration with Multi-Enzyme and Cascade Systems

Whole cell biocatalysts are particularly well suited for multi-enzyme reactions. By expressing multiple enzymes within a single host or across co-cultured strains, we enable efficient cascade reactions and metabolic channeling.

Biocatalytic Efficiency Quantification

We employ standardized enzymology assays and whole cell activity measurements to quantify reaction rates, yields, and selectivity. Long-term stability and reuse performance are also evaluated.

Scale-Up and Industrial Readiness

Our whole cell biocatalyst platforms are designed with industrial scalability in mind. Fermentation parameters, cell harvesting, storage stability, and operational robustness are addressed during development.

Available Anchor Proteins and Surface Display Systems

Anchor Proteins in Gram-Negative Microorganisms

Gram-negative bacteria possess an outer membrane, which enables diverse anchoring mechanisms:

  • Autotransporters (Type V secretion systems): Widely used for biocatalysis due to their modular design, allowing efficient surface exposure of large enzymes (e.g., AIDA-I, EstA).
  • Ice Nucleation Protein (INP): A robust outer membrane anchor supporting high enzyme display levels and compatibility with cofactor-dependent enzymes.
  • Outer membrane proteins (e.g., OprF, OmpW): Truncated β-barrel proteins enabling stable enzyme fusion and surface exposure.
  • Lipocalin-based anchors: Emerging systems with potential for specialized surface display applications.

These systems are well suited for reactions requiring direct substrate access and rapid product release.

Anchor Proteins in Gram-Positive Microorganisms

Gram-positive bacteria lack an outer membrane but possess a thick peptidoglycan layer, enabling alternative anchoring strategies:

  • PgsA-based anchors: Membrane-associated anchors enabling enzyme display on Bacillus species and related hosts.
  • NCgl1221-based anchors: Multi-pass membrane proteins used for stable surface display in Corynebacterium species.
  • Spore coat proteins (spore display): Anchors such as CotA, CotC, and CotG allow enzyme display on bacterial endospores, providing exceptional thermal and chemical stability.

Gram-positive display systems are particularly attractive for harsh industrial conditions and long-term catalyst reuse.

Bacterial whole-cell biocatalysts by surface display of enzymes: toward industrial applicationFigure 1. Schematic representation of anchor proteins for surface display used in biocatalysis in Gram-negative (a–c) and Gram- positive (d–f) microorganisms. (Schüürmann et al., 2014)

Ordering Process

Order process of whole cell biocatalysts service

Contact Our Team

Related Sections

Why Choose Us: Advantages of Our Whole Cell Biocatalyst Services

Decade-Long Experience in Biocatalysis Development

We bring extensive expertise in enzyme engineering, microbial expression, and bioprocess optimization.

Cost-Effective Alternatives to Purified Enzymes

Whole cell systems reduce purification and immobilization costs while maintaining high catalytic performance.

Advanced Surface Display Technologies

Our expertise in enzyme display enables enhanced substrate accessibility and reaction efficiency.

Integrated Process-Oriented Design

We consider the entire biocatalytic process, from host engineering to industrial operation.

Scalable and Robust Solutions

Our platforms are validated under conditions relevant to industrial production.

One-Stop, Customized Service

We provide comprehensive support across all development stages, tailored to specific client goals.

Case Studies: Whole Cell Biocatalysts in Practical Applications

Case 1: Whole-Cell Biocatalytic Production of (R)-3,5-BTPE

In this study, a highly efficient whole-cell biocatalyst was developed for the asymmetric synthesis of (R)-[3,5-bis(trifluoromethyl)phenyl] ethanol, a key chiral intermediate for Aprepitant and Fosaprepitant. A NADPH-dependent carbonyl reductase from Lactobacillus kefir (LkCR) was identified by genome mining and coexpressed with Bacillus subtilis glucose dehydrogenase (BsGDH) in E. coli for cofactor regeneration. Fusion engineering of LkCR and BsGDH using optimized linker peptides significantly enhanced NADPH recycling and catalytic efficiency. The optimized strain achieved 297.3 g/L product concentration with >99.9% ee, a 96.7% yield, and a productivity of 29.7 g/(L·h), demonstrating strong industrial potential.

Carbonyl reductase identification and development of whole-cell biotransformation for highly efficient synthesis of (R)-[3,5-bis(Trifluoromethyl)phenyl] ethanolFigure 2. Bioconversion of 3, 5-BTAP to (R)-3,5-BTPE by whole cells of E. coli/pET-BsGDH-ER/K(10 nm)-LkCR. Concentrations of 3,5-BTAP (open square) and (R)-3,5-BTPE (filled square) are shown. (Chen et al., 2016)

Case 2: Surface-Displayed Sucrase for Whole-Cell Biocatalysis

In this study, sucrase A (SacA) from Bacillus subtilis was successfully displayed on the surface of Escherichia coli using the AIDA-I autotransporter system. Fusion of sacA with the AIDA-I β-barrel enabled stable enzyme localization on the outer membrane under both aerobic and anaerobic conditions. The whole-cell catalyst efficiently hydrolyzed sucrose, producing reducing sugars and organic acids, confirming extracellular activity. AIDA–SacA showed optimal performance at 40 °C and pH 7, with a Km of 1.18 mM and good thermal stability, retaining over 80% activity after 1 h at 45 °C. This work highlights the practicality of autotransporter-based surface display for developing robust whole-cell biocatalysts.

Graphic abstract for whole-cell biocatalyst displaying sucrase AFigure 3. Enzymatic characterization of a whole-cell biocatalyst displaying sucrase A from Bacillus subtilis in Escherichia coli. (Sánchez-Andrade et al., 2025)

FAQs: Frequently Asked Questions About Whole Cell Biocatalysts

  • Q: What are the main advantages of whole cell biocatalysts over purified enzymes?

    A: Whole cell systems avoid costly enzyme purification, offer a protective cellular environment that enhances enzyme stability, and naturally support cofactor regeneration and multi-step metabolism.
  • Q: Are whole cell biocatalysts reusable?

    A: Yes. Whole cell catalysts are often reused across multiple reaction cycles, especially when immobilized, encapsulated, or engineered for surface display.
  • Q: How do you address substrate transport limitations?

    A: We apply strategies such as membrane engineering, surface enzyme display, permeabilization, or transporter co-expression to improve substrate uptake and product release.
  • Q: Can whole cell biocatalysts be scaled up for industrial production?

    A: Absolutely. Our workflows are designed with industrial scalability in mind, focusing on process robustness, reproducibility, and compatibility with large-scale fermentation.
  • Q: Are genetically modified organisms required?

    A: In most cases, yes. We support strain construction, containment strategies, and guidance on regulatory and compliance considerations.
  • Q: Can whole cell systems support multi-enzyme reactions?

    A: Yes. Whole cell platforms are particularly well suited for enzyme cascades and metabolic pathways, enabling efficient one-pot biotransformations.

References:

  1. Chen K, Li K, Deng J, Zhang B, Lin J, Wei D. Carbonyl reductase identification and development of whole-cell biotransformation for highly efficient synthesis of (R)-[3,5-bis(Trifluoromethyl)phenyl] ethanol. Microb Cell Fact. 2016;15(1):191. doi:10.1186/s12934-016-0585-5
  2. Sánchez-Andrade J, Balderas-Hernández VE, De Leon-Rodriguez A. Enzymatic characterisation of a whole-cell biocatalyst displaying sucrase a from Bacillus subtilis in Escherichia coli. Processes. 2025;13(10):3330. doi:10.3390/pr13103330
  3. Schüürmann J, Quehl P, Festel G, Jose J. Bacterial whole-cell biocatalysts by surface display of enzymes: toward industrial application. Appl Microbiol Biotechnol. 2014;98(19):8031-8046. doi:10.1007/s00253-014-5897-y

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.